Attention Deficits in Minimal Hepatic Encephalopathy

Overview

Journal Metab Brain Dis

Publisher Springer

Specialties Endocrinology
Neurology

Date 2001 Dec 1

PMID 11726083

Citations 42

Authors

K Weissenborn

S Heidenreich

J Ennen

N Ruckert

H Hecker

Affiliations

Soon will be listed here.

Abstract

Minimal hepatic encephalopathy (HE) is characterized by a decrease of psychomotor speed, and deficits in visual perception, visuo-spatial orientation, and visuo-constructive abilities. Attention deficits have also been proposed to be part of the syndrome. Several attempts were made in the past to elaborate suitable psychometric means for the assessment of minimal HE. However, there is still no "gold standard" for the diagnosis of minimal HE. We recently evaluated the so called "PSE-Test" for the assessment of minimal HE, a test battery which does not include a test predominantly aimed at the assessment of attention. We therefore presented a battery of attention tests in addition to the PSE-Test to a group of cirrhotics without clinical signs of HE compared to a healthy control group matched for age and education to determine whether the addition of special attention tests would increase the diagnostic sensitivity of the PSE-Test. It was shown that the patients with a pathological PSE-Test result differed significantly from controls in all attention tests applied, while the patients with normal PSE-Test results achieved attention test results similar to that of the controls. Thus, the PSE-Test results represent attention deficits as well as deficits in motor skills, visuo-spatial orientation, and visual construction.

Citing Articles

Role of peripheral inflammation in minimal hepatic encephalopathy.

Llansola M, Izquierdo-Altarejos P, Montoliu C, Mincheva G, Palomares-Rodriguez A, Pedrosa M Metab Brain Dis. 2024; 39(8):1667-1677.

PMID: 39177864 DOI: 10.1007/s11011-024-01417-5.

Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity.

Casanova-Ferrer F, Gallego J, Fiorillo A, Urios A, Rios M, Leon J J Transl Med. 2024; 22(1):49.

PMID: 38217008 PMC: 10787503. DOI: 10.1186/s12967-023-04844-7.

EncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients.

Hamzaoui L, Mahmoudi M, Mohamed G, Elloumi H, Laabidi A, Boubaker J F1000Res. 2023; 11:686.

PMID: 37767072 PMC: 10521086. DOI: 10.12688/f1000research.121781.2.

White matter microstructural disruption in minimal hepatic encephalopathy: a neurite orientation dispersion and density imaging (NODDI) study.

Dong Q, Lin J, Wu Y, Cao Y, Zhou M, Chen H Neuroradiology. 2023; 65(11):1589-1604.

PMID: 37486421 DOI: 10.1007/s00234-023-03201-1.

Psychometric Hepatic Encephalopathy Score for the Diagnosis of Minimal Hepatic Encephalopathy in Thai Cirrhotic Patients.

Thanapirom K, Wongwandee M, Suksawatamnuay S, Thaimai P, Siripon N, Makhasen W J Clin Med. 2023; 12(2).

PMID: 36675448 PMC: 9864758. DOI: 10.3390/jcm12020519.

References

Koch H, Schauder P, Schafer G, Dahme B, Ebel W, Vahldiek B . [Diagnosis and prevalence of latent hepatic encephalopathy]. Z Gastroenterol. 1990; 28(11):610-5. View

Klingberg T, OSullivan B, Roland P . Bilateral activation of fronto-parietal networks by incrementing demand in a working memory task. Cereb Cortex. 1997; 7(5):465-71. DOI: 10.1093/cercor/7.5.465. View

Elsass P, Lund Y, Ranek L . Encephalopathy in patients with cirrhosis of the liver. A neuropsychological study. Scand J Gastroenterol. 1978; 13(2):241-7. DOI: 10.3109/00365527809181755. View

Schomerus H, Hamster W . Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis. 1999; 13(4):361-77. DOI: 10.1023/a:1020645110880. View

Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dolle W . Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci. 1981; 26(7):622-30. DOI: 10.1007/BF01367675. View

Nobre A, Sebestyen G, Gitelman D, Mesulam M, Frackowiak R, Frith C . Functional localization of the system for visuospatial attention using positron emission tomography. Brain. 1997; 120 ( Pt 3):515-33. DOI: 10.1093/brain/120.3.515. View

Gitlin N, Lewis D, Hinkley L . The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol. 1986; 3(1):75-82. DOI: 10.1016/s0168-8278(86)80149-0. View

Lockwood A, MURPHY B, Donnelly K, Mahl T, Perini S . Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology. 1993; 18(5):1061-8. View

Lynch J, MOUNTCASTLE V, Talbot W, Yin T . Parietal lobe mechanisms for directed visual attention. J Neurophysiol. 1977; 40(2):362-89. DOI: 10.1152/jn.1977.40.2.362. View

10.

Sood G, Sarin S, Mahaptra J, Broor S . Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach. Am J Gastroenterol. 1989; 84(2):156-9. View

11.

Loguercio C, Del Vecchio-Blanco C, Coltorti M . Psychometric tests and "latent" portal-systemic encephalopathy. Br J Clin Pract. 1984; 38(11-12):407-11. View

12.

McCarthy G, Puce A, Constable R, Krystal J, Gore J . Activation of human prefrontal cortex during spatial and nonspatial working memory tasks measured by functional MRI. Cereb Cortex. 1996; 6(4):600-11. DOI: 10.1093/cercor/6.4.600. View

13.

Tarter R, Hegedus A, Van Thiel D, Edwards N, Schade R . Neurobehavioral correlates of cholestatic and hepatocellular disease: differentiation according to disease specific characteristics and severity of the identified cerebral dysfunction. Int J Neurosci. 1987; 32(3-4):901-10. DOI: 10.3109/00207458709043346. View

14.

Pardo J, Fox P, Raichle M . Localization of a human system for sustained attention by positron emission tomography. Nature. 1991; 349(6304):61-4. DOI: 10.1038/349061a0. View

15.

Mesulam M . A cortical network for directed attention and unilateral neglect. Ann Neurol. 1981; 10(4):309-25. DOI: 10.1002/ana.410100402. View

16.

Rehnstrom S, Simert G, Hansson J, Johnson G, VANG J . Chronic hepatic encephalopathy. A psychometrical study. Scand J Gastroenterol. 1977; 12(3):305-11. DOI: 10.3109/00365527709180932. View

17.

Rikkers L, Jenko P, RUDMAN D, Freides D . Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology. 1978; 75(3):462-9. View

18.

Lockwood A . "What's in a name?" Improving the care of cirrhotics. J Hepatol. 2000; 32(5):859-61. DOI: 10.1016/s0168-8278(00)80257-3. View

19.

McCrea M, Cordoba J, Vessey G, Blei A, Randolph C . Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol. 1996; 53(8):758-63. DOI: 10.1001/archneur.1996.00550080076015. View

20.

Carter C, Mintun M, Nichols T, Cohen J . Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. Am J Psychiatry. 1997; 154(12):1670-5. DOI: 10.1176/ajp.154.12.1670. View